| 000 | 00000nam 2200000zi 4500 |
| 001 | 9.918775 |
| 003 | CaOODSP |
| 005 | 20230217142033 |
| 006 | m o d f |
| 007 | cr mn||||||||| |
| 008 | 221230e202302 quca ob f000 0 eng d |
| 020 | |a9780660469096 |
| 040 | |aCaOODSP|beng|erda|cCaOODSP |
| 043 | |an-cn--- |
| 086 | 1 |aEn14-509/2023E-PDF |
| 245 | 00|aScreening assessment : |b2H-azepin-2-one, hexahydro- (caprolactam) : Chemical Abstracts Service Registry number 105-60-2. |
| 246 | 17|aScreening assessment - caprolactam |
| 264 | 1|a[Gatineau, Quebec] : |bGovernment of Canada = Gouvernement du Canada, |cFebruary 2023. |
| 264 | 4|c©2023 |
| 300 | |a1 online resource (iv, 27 pages) : |billustrations |
| 336 | |atext|btxt|2rdacontent |
| 337 | |acomputer|bc|2rdamedia |
| 338 | |aonline resource|bcr|2rdacarrier |
| 500 | |aIssued also in French under title: Évaluation préalable : ε-caprolactame (hexahydro-2H-azépin-2-one) : numéro de registre du Chemical Abstracts Service 105-60-2. |
| 500 | |aCover title. |
| 504 | |aIncludes bibliographical references. |
| 650 | 0|aCaprolactam|xEnvironmental aspects|zCanada. |
| 650 | 0|aCaprolactam|xHealth aspects|zCanada. |
| 650 | 0|aCaprolactam|xToxicology|zCanada. |
| 650 | 0|aCaprolactam|xRisk assessment|zCanada. |
| 710 | 1 |aCanada. |bEnvironment and Climate Change Canada, |eissuing body. |
| 710 | 1 |aCanada. |bHealth Canada, |eissuing body. |
| 775 | 08|tÉvaluation préalable : |w(CaOODSP)9.918774 |
| 856 | 40|qPDF|s793 KB|uhttps://publications.gc.ca/collections/collection_2023/eccc/En14-509-2023-eng.pdf |